MOLECULAR BIOSYSTEMS ALBUNEX RECOMMENDED FOR USE IN DETERMINING FALLOPIAN TUBE PATENCY, FDA PANEL VOTES; PHYSICIAN TRAINING AND LABELING CHANGES SUGGESTED
Executive Summary
Molecular Biosystems Albunex should be approved for determining fallopian tube patency through transvaginal ultrasound, provided additional training requirements are specified and minor labeling changes are made, FDA's Radiological Devices Panel concluded at a Feb. 24 meeting.